Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers.
It is the first time whole genomes have been successfully designed by AI.
The resulting 16 novel viruses were created to infect bacteria and pose no threat to people.
AI tools are rapidly advancing and have already been used to design new antibiotics.
But that is relatively simple compared with designing a new viable virus from scratch.
"This is a next step in the complexity that's designable by generative AI, this is the first time generative AI has been used to design a complete genome, it's something that can replicate and have other functions inside cells… this was new territory for us," Brian Hie, assistant professor at Stanford University, told the BBC.
The technology works similarly to large language models, like ChatGPT, which predict sequences of text.
In this instance the AI models, known as Evo1 and Evo2, predict the language of life rather than words.
The AI models were trained on genetic codes from viruses, bacteria, plants and people.
They were then refined to produce a type of virus, known as a bacteriophage, which infect only specific species of bacteria.
The Stanford researchers picked the most promising 302 AI designs and synthesised them in the lab. Of these, 16 proved effective at killing E. coli bacteria.
Samuel King, a PhD student in the lab, said they realised the phage were working in the early hours of the morning.
The phage were placed on petri dishes growing a layer of bacteria on them and the scientists waited for signs their new viruses were enjoying the feast.
Developing new phage could lead to new ways of treating infections that have become resistant to antibiotics.
But the breakthrough also points to the ability of AI to design new biology that goes beyond the natural world – what is known as synthetic biology.
Hie argues this has the potential to "massively improve human health" by developing new drugs and therapies.
But concerns have already been raised that the same technology could be used maliciously to create new diseases.
They said it was no longer a question of "whether generative viral genome design will exist" but whether it can be used without "enabling serious harm".
For example, they said new viruses with the potential to cause disease "should not be pursued".
The researchers themselves took steps to maximise safety. They excluded viruses that could infect complex organisms from the training database, performed the research on phage rather than viruses that infect people and it all took place in a secure laboratory.
Hie argues even existing safeguards go a long way towards "ensuring that the technology is used for good".
From computers bits to atoms
Viruses are not alive and it would take another significant leap for AI to generate living organisms.
The genetic code of the phage is around 5,400 base pairs (letters) long. The smallest genome of a living cell is around 500,000 base pairs. The human genome is three billion base pairs.
Hie says "it would probably be a lot of work, but not impossible" to attempt some simple organisms and they were "definitely interested in working towards" that.
Prof Marc Güell, from the synthetic biology lab at Pompeu Fabra University in Spain, said the study was a "very significant turning point" because for the "first time in history, we are beginning to design biology on a computer".
He said it "allows us to dream of exciting possibilities for tackling humanity's greatest challenges" such as developing phages to tackle disease, enzymes to treat genetic disorders and antibodies that could be used in immunotherapy.
Prof Patrick Cai, chair of synthetic genomics at the Manchester Institute of Biotechnology, said the study was an "important milestone".
"The significance extends far beyond phages – it suggests that genome language models are beginning to learn the design principles encoded by evolution, opening the door to AI-assisted genome writing."
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]














